Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-01-08 Sale |
2021-01-12 4:35 pm |
ZIOPHARM ONCOLOGY INC | ZIOP | Buck Jill EVP, GM Gene Therapy |
27,894 | $3.12 | $87,029 | 199,516 (Direct) |
View |
| 2021-01-08 Sale |
2021-01-12 4:34 pm |
ZIOPHARM ONCOLOGY INC | ZIOP | Lafond Kevin G SVP, Treasurer & CAO |
18,020 | $3.09 | $55,682 | 63,965 (Direct) |
View |
| 2021-01-08 Sale |
2021-01-12 4:33 pm |
ZIOPHARM ONCOLOGY INC | ZIOP | Hadfield Robert General Counsel and Secretary |
26,500 | $3.12 | $82,680 | 133,319 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-06 5:03 pm |
ZIOPHARM ONCOLOGY INC | ZIOP | De Groot Eleanor EVP, GM Cell Therapy |
21,620 | $2.72 | $58,806 | 206,413 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-06 5:02 pm |
ZIOPHARM ONCOLOGY INC | ZIOP | Cooper Laurence James Neil President and CEO |
105,693 | $2.71 | $286,428 | 1,799,280 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-03-22 5:31 pm |
N/A N/A |
ZIOPHARM ONCOLOGY INC | ZIOP | Weis Holger Director |
0 | $0 | 87,440 (Direct) |
View |
Ownership |
2021-03-22 5:30 pm |
N/A N/A |
ZIOPHARM ONCOLOGY INC | ZIOP | Vieser Jaime Director |
0 | $0 | 926,154 (Direct) |
View |
Ownership |
2021-03-22 5:28 pm |
N/A N/A |
ZIOPHARM ONCOLOGY INC | ZIOP | Postma Robert W Director |
0 | $0 | 6,324,914 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-08 5:30 pm |
N/A 2031-03-04 |
ZIOPHARM ONCOLOGY INC | ZIOP | Buck Jill EVP, GM Gene Therapy |
267,750 | $0 | 467,266 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-08 5:29 pm |
N/A 2031-03-04 |
ZIOPHARM ONCOLOGY INC | ZIOP | Hadfield Robert Chief Legal Officer and Sec. |
369,750 | $0 | 503,069 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-08 5:28 pm |
N/A 2031-03-04 |
ZIOPHARM ONCOLOGY INC | ZIOP | Hagen Heidi Interim CEO |
765,000 | $0 | 797,119 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-08 5:26 pm |
N/A 2031-03-04 |
ZIOPHARM ONCOLOGY INC | ZIOP | De Groot Eleanor EVP, GM Cell Therapy |
432,013 | $0 | 638,426 (Direct) |
View |
| 2020-10-08 Option Award |
2020-10-13 4:55 pm |
N/A 2030-10-08 |
ZIOPHARM ONCOLOGY INC | ZIOP | BUCHI J KEVIN Director |
146,190 | $0 | 146,190 (Direct) |
View |